Thromboelastography in Patients with Acute Ischemic Stroke
Authors:
- 27 September 2012
- journal article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (2) , 194-201
Abstract
Background: Thromboelastography measures the dynamics of coagulation. There are limited data about thromboelastography in acute ischemic stroke other than a single study from 1974 suggesting that acute ischemic stroke patients are hypercoagulable. There have been no studies of thromboelastography in the thrombolytic era despite its potential usefulness as a measure of clot lysis. This study was designed to provide initial thromboelastography data in stroke patients before and after tissue plasminogen activator therapy and to provide the necessary preliminary data for further study of thromboelastography's ability to identify clot subtype and predict response to tissue plasminogen activator therapy. Methods: All acute ischemic stroke patients presenting between 11/2009 and 2/2011 eligible for tissue plasminogen activator therapy were screened and 56 enrolled. Blood was drawn before (52 patients) and 10 mins after tissue plasminogen activator bolus (30 patients). Demographics, vitals, labs, 24 h National Institutes of Health Stroke Scale, and computed tomography scan results were collected. Patients were compared with normal controls. Results: Acute ischemic stroke patients had shorter R (4·8 ± 1·5 vs. 6·0 ± 1·7 min, P = 0·0004), greater a Angle (65·0 ± 7·6 vs. 61·5 ± 5·9°, P = 0·01), and shorter K (1·7 ± 0·7 vs. 2·1 ± 0·7 min, P = 0·002) indicating faster clotting. Additionally, a subset formed clots with stronger platelet-fibrin matrices. Treatment with tissue plasminogen activator resulted in reduction in all indices of clot strength (LY30 = 0 (0–0·4) vs. 94·4 (15·2–95·3) P < 0·0001); however, there was considerable variability in response. Conclusions: Thromboelastography demonstrates that many acute ischemic stroke patients are hypercoaguable. Thromboelastography values reflect variable clot subtype and response to tissue plasminogen activator. Further study based on these data will determine if thromboelastography is useful for measuring the dynamic aspects of clot formation and monitoring lytic therapy.Keywords
This publication has 32 references indexed in Scilit:
- CT and MRI Early Vessel Signs Reflect Clot Composition in Acute StrokeStroke, 2011
- In Normal Controls, Both Age and Gender Affect Coagulability as Measured by ThrombelastographyAnesthesia & Analgesia, 2010
- Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin StructureArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Evaluation of the Contribution of Platelets to Clot Strength by Thromboelastography in Rabbits: The Role of Tissue Factor and Cytochalasin DAnesthesia & Analgesia, 2000
- Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac SurgeryAnesthesia & Analgesia, 1999
- Hemostatic Markers in Acute Ischemic StrokeStroke, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Markers of a hypercoagulable state following acute ischemic stroke.Stroke, 1992
- Hemostatic markers in acute stroke.Stroke, 1989
- Thromboelastographic Studies in Cerebral InfarctionStroke, 1974